Unleash Multifunctional Role of Long Noncoding RNAs Biomarker Panel in Breast Cancer: A Predictor Classification Model

References

• Siegel RL , MillerKD , JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Akram M , IqbalM , DaniyalM , KhanAU. Awareness and current knowledge of breast cancer. Biol. Res.50(1), 33 (2017).
   PubMed Web of Science ®Google Scholar
• Guttman M , AmitI , GarberMet al. Chromatin signature reveals over a thousand highly conserved large noncoding RNAs in mammals. Nature458(7235), 223–227 (2009).
   PubMed Web of Science ®Google Scholar
• Mercer TR , DingerME , MattickJS. Long noncoding RNAs: insights into functions. Nat. Rev. Genet.10(3), 155–159 (2009).
   PubMed Web of Science ®Google Scholar
• Beermann J , PiccoliMT , ViereckJ , ThumT. Noncoding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev.96(4), 1297–1325 (2016).
   PubMed Web of Science ®Google Scholar
• Prensner JR , ChinnaiyanAM. The emergence of lncRNAs in cancer biology. Cancer Discov.1(5), 391–407 (2011).
   PubMed Web of Science ®Google Scholar
• Bhan A , SoleimaniM , MandalSS. Long noncoding RNA and cancer: a new paradigm. Cancer Res.77(15), 3965–3981 (2017).
   PubMed Web of Science ®Google Scholar
• Youness RA , GadMZ. Long noncoding RNAs: functional regulatory players in breast cancer. Noncoding RNA Res.4(1), 36–44 (2019).
   PubMed Web of Science ®Google Scholar
• Shi T , GaoG , CaoY. Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Dis. Markers2016, 9085195 (2016).
   PubMed Web of Science ®Google Scholar
• Toraih EA , EllawindyA , FalaSYet al. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma. Biomed. Pharmacother.102, 653–669 (2018).
   PubMed Web of Science ®Google Scholar
• Toraih EA , AlghamdiSA , El-WazirAet al. Dual biomarkers long noncoding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors. PLoS ONE13(10), e0198231 (2018).
   PubMed Web of Science ®Google Scholar
• Zhou S , HeY , YangSet al. The regulatory roles of lncRNAs in the process of breast cancer invasion and metastasis. Biosci. Rep.38(5), BSR20180772 (2018).
   PubMedGoogle Scholar
• Bao Z , YangZ , HuangZ , ZhouY , CuiQ , DongD. LncRNADisease 2.0: an updated database of long noncoding RNA-associated diseases. Nucleic Acids Res.47(D1), D1034–D1037 (2019).
   PubMed Web of Science ®Google Scholar
• Fawzy MS , ToraihEA , AbdallahHY. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1): a molecular predictor of poor survival in glioblastoma multiforme in Egyptian patients. Egyptian J. Medical Human Gen.18(3), 231–239 (2017).
   Google Scholar
• Zuo Y , LiY , ZhouZ , MaM , FuK. Long noncoding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Biomed. Pharmacother.95, 922–928 (2017).
   PubMed Web of Science ®Google Scholar
• Li Z , XuL , LiuYet al. LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever. Am. J. Transl. Res.10(10), 3186–3197 (2018).
   PubMed Web of Science ®Google Scholar
• Tripathi V , EllisJD , ShenZet al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell39(6), 925–938 (2010).
   PubMed Web of Science ®Google Scholar
• Gupta RA , ShahN , WangKCet al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature464(7291), 1071–1076 (2010).
   PubMed Web of Science ®Google Scholar
• Tao S , HeH , ChenQ. Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer. J. Transl. Med.13, 131 (2015).
   PubMed Web of Science ®Google Scholar
• Chisholm KM , WanY , LiR , MontgomeryKD , ChangHY , WestRB. Detection of long noncoding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS ONE7(10), e47998 (2012).
   PubMed Web of Science ®Google Scholar
• Sorensen KP , ThomassenM , TanQet al. Long noncoding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat.142(3), 529–536 (2013).
   PubMed Web of Science ®Google Scholar
• Colombo T , FarinaL , MacinoG , PaciP. PVT1: a rising star among oncogenic long noncoding RNAs. Biomed. Res. Int.2015, 304208 (2015).
   PubMed Web of Science ®Google Scholar
• Guan Y , KuoWL , StilwellJLet al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin. Cancer Res.13(19), 5745–5755 (2007).
   PubMed Web of Science ®Google Scholar
• Kung JT , ColognoriD , LeeJT. Long noncoding RNAs: past, present, and future. Genetics193(3), 651–669 (2013).
   PubMed Web of Science ®Google Scholar
• Collette J , LeBourhis X , AdriaenssensE. Regulation of Human Breast Cancer by the Long noncoding RNA H19. Int. J. Mol. Sci.18(11), (2017).
   PubMed Web of Science ®Google Scholar
• Yang S , ChenJ , YuYet al. Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population. Cancer Manag. Res.10, 4641–4652 (2018).
   PubMed Web of Science ®Google Scholar
• Li Y , JiangB , ZhuHet al. Inhibition of long noncoding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer. Tumour Biol.39(6), 1010428317705790 (2017).
   Google Scholar
• Pickard MR , WilliamsGT. Regulation of apoptosis by long noncoding RNA GAS5 in breast cancer cells: implications for chemotherapy. Breast Cancer Res. Treat.145(2), 359–370 (2014).
   PubMed Web of Science ®Google Scholar
• Meseure D , VacherS , AlsibaiKDet al. Expression of ANRIL-polycomb complexes-CDKN2A/B/ARF Genes in breast tumors: identification of a two-gene (EZH2/CBX7) signature with independent prognostic value. Mol. Cancer Res.14(7), 623–633 (2016).
   PubMed Web of Science ®Google Scholar
• Lou KX , LiZH , WangPet al. Long noncoding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Eur. Rev. Med. Pharmacol. Sci.22(5), 1358–1365 (2018).
   PubMed Web of Science ®Google Scholar
• Luan T , ZhangX , WangSet al. Long noncoding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p. Oncotarget8(44), 76153–76164 (2017).
   PubMedGoogle Scholar
• Li Y , JiangB , WuXet al. Long noncoding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells. Biochem. Biophys. Res. Commun.503(1), 45–50 (2018).
   PubMed Web of Science ®Google Scholar
• Sparano JA . Prognostic gene expression assays in breast cancer: are two better than one?NPJ Breast Cancer4, 11 (2018).
   PubMed Web of Science ®Google Scholar
• Huang S , MurphyL , XuW. Genes and functions from breast cancer signatures. BMC Cancer18(1), 473 (2018).
   PubMedGoogle Scholar
• Vieira AF , SchmittF. An update on breast cancer multigene prognostic tests-emergent clinical biomarkers. Front. Med. (Lausanne)5, 248 (2018).
   PubMed Web of Science ®Google Scholar
• Toraih EA , MohammedEA , FarragS , RamsisN , HosnyS. Pilot study of serum microRNA-21 as a diagnostic and prognostic biomarker in Egyptian breast cancer patients. Mol. Diagn. Ther.19(3), 179–190 (2015).
   PubMed Web of Science ®Google Scholar
• Kataja V , CastiglioneM , GroupEGW. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol.20(Suppl. 4), S10–S14 (2009).
   PubMedGoogle Scholar
• Meyer JS , AlvarezC , MilikowskiCet al. Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod. Pathol.18(8), 1067–1078 (2005).
   PubMed Web of Science ®Google Scholar
• Lowery AJ , MillerN , DevaneyAet al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res.11(3), R27 (2009).
   PubMed Web of Science ®Google Scholar
• Yan LX , HuangXF , ShaoQet al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA14(11), 2348–2360 (2008).
   PubMed Web of Science ®Google Scholar
• D’eredita G , GiardinaC , MartellottaM , NataleT , FerrareseF. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur. J. Cancer37(5), 591–596 (2001).
   PubMed Web of Science ®Google Scholar
• Guerra I , AlgortaJ , DiazDe Otazu R , PelayoA , FarinaJ. Immunohistochemical prognostic index for breast cancer in young women. Mol. Pathol.56(6), 323–327 (2003).
   PubMedGoogle Scholar
• Fawzy MS , MohammedEA , AhmedAS , Fakhr-EldeenA. Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: a pilot study. Meta Gene4, 73–84 (2015).
   PubMedGoogle Scholar
• Bustin SA , BenesV , GarsonJAet al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem.55(4), 611–622 (2009).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods25(4), 402–408 (2001).
   PubMed Web of Science ®Google Scholar
• Motawi TM , SadikNA , ShakerOG , ElMasry MR , MoharebF. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women. Gene590(2), 210–219 (2016).
   PubMed Web of Science ®Google Scholar
• Wang C , WangL , DingYet al. LncRNA structural characteristics in epigenetic regulation. Int. J. Mol. Sci.18(12), 2659 (2017).
   PubMed Web of Science ®Google Scholar
• Tian T , GongZ , WangMet al. Identification of long noncoding RNA signatures in triple-negative breast cancer. Cancer Cell Int.18, 103 (2018).
   PubMed Web of Science ®Google Scholar
• Gibb EA , BrownCJ , LamWL. The functional role of long noncoding RNA in human carcinomas. Mol. Cancer10, 38 (2011).
   PubMed Web of Science ®Google Scholar
• Li L , FengT , LianY , ZhangG , GarenA , SongX. Role of human noncoding RNAs in the control of tumorigenesis. Proc. Natl Acad. Sci. USA106(31), 12956–12961 (2009).
   PubMed Web of Science ®Google Scholar
• Amodio N , RaimondiL , JuliGet al. MALAT1: a druggable long noncoding RNA for targeted anti-cancer approaches. J. Hematol. Oncol.11(1), 63 (2018).
   PubMed Web of Science ®Google Scholar
• Sun Y , MaL. New insights into long noncoding RNA MALAT1 in cancer and metastasis. Cancers (Basel)11(2), 216 (2019).
   PubMed Web of Science ®Google Scholar
• Moran VA , PereraRJ , KhalilAM. Emerging functional and mechanistic paradigms of mammalian long noncoding RNAs. Nucleic Acids Res.40(14), 6391–6400 (2012).
   PubMed Web of Science ®Google Scholar
• Qi P , DuX. The long noncoding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod. Pathol.26(2), 155–165 (2013).
   PubMed Web of Science ®Google Scholar
• Huang NS , ChiYY , XueJYet al. Long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer. Oncotarget7(25), 37957–37965 (2016).
   PubMedGoogle Scholar
• Miao Y , FanR , ChenL , QianH. Clinical significance of long noncoding RNA MALAT1 expression in tissue and serum of breast cancer. Ann. Clin. Lab. Sci.46(4), 418–424 (2016).
   PubMed Web of Science ®Google Scholar
• Shuai P , ZhouY , GongBet al. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis. Springerplus5(1), 1721 (2016).
   PubMedGoogle Scholar
• Wang Z , KatsarosD , BigliaNet al. High expression of long noncoding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Breast Cancer Res. Treat.171(2), 261–271 (2018).
   PubMed Web of Science ®Google Scholar
• Zidan HE , KaramRA , El-SeifiOS , AbdElrahman TM. Circulating long noncoding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer. Cancer Genet.220, 32–37 (2018).
   PubMed Web of Science ®Google Scholar
• Jadaliha M , ZongX , MalakarPet al. Functional and prognostic significance of long noncoding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer. Oncotarget7(26), 40418–40436 (2016).
   PubMedGoogle Scholar
• Kim J , PiaoHL , KimBJet al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat. Genet.50(12), 1705–1715 (2018).
   PubMed Web of Science ®Google Scholar
• Eastlack SC , DongS , MoYY , AlahariSK. Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer. PLoS ONE13(6), e0198945 (2018).
   PubMed Web of Science ®Google Scholar
• Arun G , SpectorDL. MALAT1 long noncoding RNA and breast cancer. RNA Biol.16(6), 860–863 (2019).
   PubMed Web of Science ®Google Scholar
• Ma C , ShiX , ZhuQet al. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers. Tumour Biol.37(2), 1437–1444 (2016).
   PubMedGoogle Scholar
• Ghaforui-Fard S , TaheriM. Growth arrest specific transcript 5 in tumorigenesis process: an update on the expression pattern and genomic variants. Biomed. Pharmacother.112, 108723 (2019).
   PubMed Web of Science ®Google Scholar
• Mourtada-Maarabouni M , PickardMR , HedgeVL , FarzanehF , WilliamsGT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene28(2), 195–208 (2009).
   PubMed Web of Science ®Google Scholar
• Huarte M , GuttmanM , FeldserDet al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell142(3), 409–419 (2010).
   PubMed Web of Science ®Google Scholar
• Gutschner T , DiederichsS. The hallmarks of cancer: a long noncoding RNA point of view. RNA Biol9(6), 703–719 (2012).
   PubMed Web of Science ®Google Scholar
• Ding YX , DuanKC , ChenSL. [Low expression of lncRNA-GAS5 promotes epithelial–mesenchymal transition of breast cancer cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao37(11), 1427–1435 (2017).
   PubMedGoogle Scholar
• Han L , MaP , LiuSM , ZhouX. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Tumour Biol.37(5), 6847–6854 (2016).
   PubMedGoogle Scholar
• Mansoori Y , TabeiMB , AskariAet al. Expression levels of breast cancer-related GAS5 and LSINCT5 lncRNAs in cancer-free breast tissue: molecular associations with age at menarche and obesity. Breast J.24(6), 876–882 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang L , SongX , WangXet al. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer. Breast Cancer Res. Treat.152(1), 199–208 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang KJ , ZhangY , LuoZLet al. [Long noncoding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis]. Nan Fang Yi Ke Da Xue Xue Bao36(4), 488–492 (2016).
   PubMedGoogle Scholar
• Zhang Y , ZhangK , LuoZ , LiuL , WuL , LiuJ. Circulating long noncoding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer. Thorac Cancer7(6), 627–632 (2016).
   PubMed Web of Science ®Google Scholar
• Soudyab M , IranpourM , Ghafouri-FardS. The Role of Long noncoding RNAs in Breast Cancer. Arch. Iran Med.19(7), 508–517 (2016).
   PubMed Web of Science ®Google Scholar
• He H , WeiZ , DuFet al. Transcription of HOTAIR is regulated by RhoC-MRTF-A-SRF signaling pathway in human breast cancer cells. Cell. Signal.31, 87–95 (2017).
   PubMed Web of Science ®Google Scholar
• Zhuang Y , NguyenHT , BurowMEet al. Elevated expression of long intergenic noncoding RNA HOTAIR in a basal-like variant of MCF-7 breast cancer cells. Mol. Carcinog.54(12), 1656–1667 (2015).
   PubMed Web of Science ®Google Scholar
• Ding W , RenJ , RenH , WangD. Long noncoding RNA HOTAIR modulates MiR-206-mediated Bcl-w signaling to facilitate cell proliferation in breast cancer. Sci. Rep.7(1), 17261 (2017).
   PubMedGoogle Scholar
• Lu R , ZhangJ , ZhangWet al. Circulating HOTAIR expression predicts the clinical response to neoadjuvant chemotherapy in patients with breast cancer. Cancer Biomark22(2), 249–256 (2018).
   PubMed Web of Science ®Google Scholar
• Wang YL , OverstreetAM , ChenMSet al. Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR. Oncotarget6(13), 11150–11161 (2015).
   PubMedGoogle Scholar
• Lu L , ZhuG , ZhangCet al. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res. Treat.136(3), 875–883 (2012).
   PubMed Web of Science ®Google Scholar
• Sarver AL , MurrayCD , TemizNA , TsengYY , BagchiA. MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer. Cell Cycle15(7), 881–885 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Y , ZhouJ , WangZ , WangP , LiS. Upregulation of SOX2 activated LncRNA PVT1 expression promotes breast cancer cell growth and invasion. Biochem. Biophys. Res. Commun.493(1), 429–436 (2017).
   PubMed Web of Science ®Google Scholar
• Derderian C , OrunmuyiAT , Olapade-OlaopaEO , OgunwobiOO. PVT1 signaling is a mediator of cancer progression. Front. Oncol.9, 502 (2019).
   PubMed Web of Science ®Google Scholar
• Liu C , JinJ , LiangDet al. Long noncoding RNA PVT1 as a novel predictor of metastasis, clinicopathological characteristics and prognosis in human cancers: a meta-analysis. Pathol. Oncol. Res.25(3), 837–847 (2019).
   PubMed Web of Science ®Google Scholar
• Zou B , WangD , XuKet al. Prognostic value of long noncoding RNA plasmacytoma variant translocation1 in human solid tumors: a meta-analysis. Medicine (Baltimore)98(27), e16087 (2019).
   PubMed Web of Science ®Google Scholar
• Eades G , WolfsonB , ZhangY , LiQ , YaoY , ZhouQ. lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol. Cancer Res.13(2), 330–338 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang HY , LiangF , ZhangJW , WangF , WangL , KangXG. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205. Cancer Chemother. Pharmacol.79(2), 327–337 (2017).
   PubMed Web of Science ®Google Scholar
• Hou P , ZhaoY , LiZet al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis.5, e1287 (2014).
   PubMed Web of Science ®Google Scholar
• Chen YM , LiuY , WeiHY , LvKZ , FuP. Linc-ROR induces epithelial–mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumour Biol.37(8), 10861–10870 (2016).
   PubMedGoogle Scholar
• Lottin S , AdriaenssensE , DupressoirTet al. Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis23(11), 1885–1895 (2002).
   PubMed Web of Science ®Google Scholar
• Berteaux N , LottinS , MonteDet al. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J. Biol. Chem.280(33), 29625–29636 (2005).
   PubMed Web of Science ®Google Scholar
• Barsyte-Lovejoy D , LauSK , BoutrosPCet al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res.66(10), 5330–5337 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou W , YeXL , XuJet al. The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci. Signal.10(483), eaak9557 (2017).
   PubMed Web of Science ®Google Scholar
• Sun H , WangG , PengYet al. H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells. Oncol. Rep.33(6), 3045–3052 (2015).
   PubMed Web of Science ®Google Scholar
• Iranpour M , SoudyabM , GeranpayehLet al. Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol.37(3), 2933–2940 (2016).
   PubMedGoogle Scholar
• Xu ST , XuJH , ZhengZRet al. Long noncoding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer. Biomed. Pharmacother.96, 14–21 (2017).
   PubMed Web of Science ®Google Scholar
• Liu M , XingLQ , LiuYJ. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Medicine (Baltimore)96(9), e6222 (2017).
   PubMed Web of Science ®Google Scholar
• Jiang J , ShiSH , LiXJet al. Long noncoding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer. Oncol. Lett.15(6), 9543–9552 (2018).
   PubMed Web of Science ®Google Scholar
• Sun C , HuangL , LiZet al. Long noncoding RNA MIAT in development and disease: a new player in an old game. J. Biomed. Sci.25(1), 23 (2018).
   PubMed Web of Science ®Google Scholar
• Almnaseer ZA , Mourtada-MaarabouniM. Long noncoding RNA MIAT regulates apoptosis and the apoptotic response to chemotherapeutic agents in breast cancer cell lines. Biosci. Rep.38(4), BSR20180704 (2018).
   PubMedGoogle Scholar
• Alipoor FJ , AsadiMH , Torkzadeh-MahaniM. MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line. J. Cell. Biochem.119(8), 6470–6481 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang Q , MaR , WangJet al. LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data. BMC Genomics16(Suppl. 3), S2 (2015).
   PubMedGoogle Scholar